investorscraft@gmail.com

Intrinsic ValueCorteva, Inc. (2X0.DE)

Previous Close61.52
Intrinsic Value
Upside potential
Previous Close
61.52

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Corteva, Inc. is a leading global agricultural company specializing in seed and crop protection solutions. Operating through two core segments—seed and crop protection—the company provides high-performance germplasm and innovative crop protection products designed to enhance yield and resilience. Corteva serves a diverse range of crops, including corn, soybean, wheat, and specialty crops like fruits and vegetables, positioning itself as a key player in sustainable agriculture. The company’s integrated approach combines advanced biotechnology with agronomic expertise, catering to both large-scale field crops and high-value specialty markets. Its strong R&D capabilities and extensive distribution network reinforce its competitive edge in the industrial materials sector. Corteva’s market position is further bolstered by its ability to address evolving farmer needs, regulatory trends, and environmental challenges, making it a trusted partner in global food production.

Revenue Profitability And Efficiency

Corteva reported revenue of €16.91 billion for FY 2024, with net income of €907 million, reflecting a diluted EPS of €1.22. The company generated €2.15 billion in operating cash flow, demonstrating solid operational efficiency. Capital expenditures stood at €597 million, indicating disciplined investment in growth initiatives. These figures underscore Corteva’s ability to balance profitability with strategic reinvestment.

Earnings Power And Capital Efficiency

Corteva’s earnings power is supported by its diversified product portfolio and strong market presence. The company’s capital efficiency is evident in its ability to generate substantial operating cash flow relative to its capital expenditures. With a focus on high-margin seed and crop protection products, Corteva maintains robust returns on invested capital, driven by innovation and scale.

Balance Sheet And Financial Health

Corteva’s balance sheet remains healthy, with €3.11 billion in cash and equivalents and total debt of €3.18 billion. The company’s conservative leverage and liquidity position provide flexibility for growth and shareholder returns. Its strong cash position supports ongoing R&D and potential acquisitions, ensuring long-term competitiveness.

Growth Trends And Dividend Policy

Corteva has demonstrated steady growth, supported by demand for advanced agricultural solutions. The company pays a dividend of €0.65 per share, reflecting a commitment to returning capital to shareholders. Future growth is expected to be driven by product innovation, geographic expansion, and sustainability initiatives, aligning with global agricultural trends.

Valuation And Market Expectations

With a market capitalization of €36.52 billion and a beta of 0.77, Corteva is viewed as a stable investment in the agricultural sector. The company’s valuation reflects its leadership position, growth potential, and resilience to market volatility. Investor expectations are anchored in Corteva’s ability to deliver consistent earnings and capitalize on long-term industry trends.

Strategic Advantages And Outlook

Corteva’s strategic advantages include its strong R&D pipeline, global distribution network, and focus on sustainable agriculture. The company is well-positioned to benefit from increasing global food demand and regulatory shifts toward environmentally friendly farming practices. The outlook remains positive, with growth expected in both seed and crop protection segments, supported by innovation and operational excellence.

Sources

Company filings, investor presentations, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount